Skip to main content

Analysis of polymorphisms in the circumsporozoite protein gene of Plasmodium vivax isolates from Henan Province, China



Plasmodium vivax malaria has historically been a major source of disease in Henan, China. In the 1970s, the morbidity of malaria was highest in the country. With support from the government and the efforts of healthcare personnel, the reported malaria cases have declined dramatically and a national elimination programme was launched in 2010. To achieve the goal, it is essential to study the diversity of autochthonous malaria and transmission of Plasmodium parasites, which will provide baseline data for disease control and management.


Thirty-two P. vivax isolates from Henan province were collected from 2008 to 2011, and circumsporozoite protein (csp) genes were analysed to estimate the genetic diversity of this parasite.


The assessment of csp sequences indicated that all the isolates were the VK210 type, however, none of them was identical to the VK210 strain. The sequences displayed variations in the central region, and eight sub-types were observed. Among the sub-types, HN7 was the most prevalent (37.5%), followed by HN3 (34.4%). A total of 653 repeat units were discovered in 32 Henan isolates. Nucleotide sequences were grouped in 13 unique repeat nucleotide sequence allotypes that coded for 7 different repeated amino acid allotypes. B (GNGAGGQAA) and D (GDRAAGQPA) were more frequent based on the results; they represented 53.9% (352/653) of the total. In comparison to the basic repeat units of VK210, more than 75% of the central repeat units had at least one non-synonymous nucleotide change.


Recent P. vivax populations in Henan province showed some degree of genetic diversity in csp, with 8 sub-types among 32 samples. Meantime, the results also suggested its relative conserved parasite populations. This could provide interesting baseline data that allow identifying whether potential new cases differ from the parasites already circulating in the area.


Malaria remains one of the most important communicable diseases in the world despite enormous control efforts over many decades. A total of 216 million cases of malaria occurred in 2016, which led to 445,000 deaths [1]. Plasmodium vivax is a human parasite that is distributed globally. Approximately 40% of the world’s population were threatened, resulting in 132–391 million clinical infections annually [2]. In many parts of Central and South America, Asia, and Eastern Mediterranean Regions, P. vivax is the most prevalent of the four human parasites [3]. Although infections by P. vivax have a low rate of mortality and they are often regarded as benign, P. vivax can result in dire clinical sequelae as well as producing harmful economic consequences for the individual, family, and even the society [4, 5]. Moreover, it has been shown that P. vivax during pregnancy can be attributed to maternal anemia, low birth weight [2], and the risk of neonatal deaths [6].

In China, malaria was highly endemic historically, Yunnan and Hainan Province were the most severe endemic areas with transmission of Plasmodium falciparum and P. vivax [7]. With support from the Chinese Government and the dedicated efforts of healthcare personnel, malaria transmission was substantially reduced to very low levels by 1994. However, from 2005, malaria re-emerged and a large number of cases were reported in the central provinces of China with P. vivax as the only species causing infection. The central region, including Anhui, Henan, Shandong, Jiangsu and Hubei province, where the predominant vector mosquito was Anopheles sinensis were the most seriously affected area in these years [8,9,10,11,12].

Henan province, located in central China, has a history of malaria epidemics with endemic P. vivax throughout the province [13]. In the early 1970s, the morbidity reported was 16.9%, the number of the malaria cases was highest in the country [14]. Afterwards, the reported malaria cases have declined dramatically through years of efforts. There were no reports of autochthonous case by the end of 2012. In terms of the imported cases, people coming from Southeast Asia occupied nearly half of the imported vivax malaria cases, the following was those from East Africa in the last decade. In 2010, the Ministry of Health of the Peoples’ Republic of China launched a national malaria elimination programme to effectively protect and promote public health. The goal was to abolish local malaria transmission by 2015 in most of the regions, with the exception of the region around the border in Yunnan province, and the expectation was to completely eliminate malaria in China by 2020. To achieve the goal, it is essential to study the diversity of autochthonous malaria and transmission of Plasmodium parasites in endemic areas, which will provide baseline data for disease control and management.

In recent years, several genetic markers have been used to study P. vivax population diversity in many provinces of China, such as microsatellites and the genes encoding csp, merozoite surface protein 1 (msp-1), merozoite surface proteins 3 (msp-3) and mitochondrial DNA [15,16,17,18,19,20,21]. However, the population structure of P. vivax in this malaria endemic area is unknown. Circumsporozoite protein (CSP) found in all malaria parasites is the major cell surface protein of the Plasmodium sporozoite [22]. This protein plays many roles, including salivary gland invasion in mosquitoes, sporozoite maturation, and hepatocyte invasion in humans [23]. It has three distinct domains: a central repetitive domain with varying numbers of tandem repeats and highly conserved domains at both the amino and carboxyl ends [24]. Previous reports classified this sequence into three types according to the amino acid composition of repeats: variant or VK247, common or VK210, and P. vivax-like [25]. The classic VK210 strain has a GDRA(A/D)GQPA amino acid repeat and the variant form, VK247, which was first identified in Thailand, has an ANGAGNQPG amino acid repeat in the central region [26]. The P. vivax-like variant, which was first extracted in Papua New Guinea, resembles VK247 and VK210 morphologically, but it has a distinctive repeated area of the central region of the csp gene(APGANQ[E/G]GGAA) [27].

This study aimed to determine the molecular characterization of vivax malaria to produce a genetic characterization of CSP in P. vivax from Henan in order to provide baseline molecular epidemiology data to inform ongoing and future malaria elimination efforts.


Study area

The study location was Henan province (north latitude 31° 23′–36° 22′ and east longitude 110° 21′–116° 39′). Henan province includes 159 county-level divisions with a total population of 106 million. The mountainous areas comprise 26.6% of the region, plain areas comprise 55.7% in the river valley and hilly areas comprise 17.7%. The climate ranges from subtropical monsoons with average temperatures between 12 and 16 °C and a warm temperate climate. The rainfall is between 500 and 900 mm per year. The specific climate and geographical conditions of this area make mosquito breeding favourable and the main malaria vectors are An. sinensis and Anopheles anthropophagus [28]. Henan experienced a P. vivax resurgence from 2005 to 2009 (Fig. 1), the majority of patients came from Nanyang and Shangqiu city, located in the southwest and east of the Province, separately (Fig. 2).

Fig. 1

Malaria Incidence in Henan Province during 2005–2011

Fig. 2

Malaria situation and Sub-types distribution in Henan province, China. The constituent ratio of the reported cases in different cities during 2005–2011 was shown in the map. The cities with the most reported cases was Shangqiu city, the following was Nanyang city. a The eight sequences from Nanyang (HNNY) parasites represent four sub-types. b The twenty-two sequences from Shangqiu (HNSQ) parasites represent six sub-types

Sample collection

Plasmodium vivax-infected blood samples from patients, including venous blood samples and finger-prick blood samples were adsorbed onto filter paper, were collected during 2008–2011 in Henan province. All the patients were Chinese nationals with no history of travel to neighbouring countries or provinces within the past month. Blood samples were collected from symptomatic patients with blood smears that tested positive for P. vivax at the local clinic or hospitals. A blood sample of 2 ml was taken with venipuncture for molecular analysis before anti-malarial treatment was given. Samples were collected in Ethylene diamine tetraacetic acid (EDTA) tubes kept at − 20 °C until DNA extraction. Along with blood sampling, epidemiological and clinical data were reported on a standardized form. All samples were sent to the Henan Center for Disease Control and Prevention (Henan CDC) for confirmation the specious by microscopy and PCR. Patients or the guardians of children gave informed consent to participate in this study and the study was approved by the Ethical Review Committee of Henan CDC.

DNA template preparation

Extraction of P. vivax genomic DNA from blood samples was performed with the QIAamp DNA Mini kit (QIAGEN Inc, German) according to the manufacturer’s instructions. TE buffer (10 mM Tris–HCL, pH 8.0, 0.1 M EDTA) was used to dissolve the DNA and then it was stored at − 20 °C until use. A 1.5% agarose gel stained with ethidium bromide was used to check the quality of the DNA and then it was visualized with UV illumination. The presence of other Plasmodium species was assessed with a previously described PCR protocol [29].

Molecular markers

A nested PCR amplification method was used to amplify the csp gene following previously reported protocols with some minor modifications [30]. The cycling conditions and primers were as follows: VCS-OF (ATGTAGATCTGTCCAAGGCCATAAA), VCS-OR (TAATTGAATAATGCTAGGACTAACAATATG) as primary primers and VCS-NF (GCAGAACCAAAAAATCCACGTGAAAATAAG), VCS-NR (CCAACGGTAGCTCTAACTTTATCTAGGTAT) as a nested primer. Amplification reactions were performed in a total volume of 20 µl. A total of 1 µl of genomic DNA prepared from the blood samples was used in the primary amplification reactions and 1 µl of the primary reaction amplification product was used as a template in the secondary amplification reactions. The PCR program was: 95 °C for 4 min for initial denaturation, 25 cycles of denaturation at 94 °C for 1 min, primer annealing at 58 °C for 1 min for the primary reaction and 62 °C for 1 min for the nested reaction, extension at 72 °C for 1 min and a final extension step at 72 °C for 7 min.

Analysis of the amplification product

The nested PCR products of csp genes were electrophoresed on a 1.5% agarose gel. Then directly sequenced in both directions using an ABI PRISM3730 DNA sequencer (Sangon Biotech Co., Ltd, China). The sequences were edited and aligned with the programs Chromsa Pro and BioEdit, phylogenetic trees were made using the Molecular Evolutionary Genetics Analysis (MEGA) 7.0. The reliability of the phylogenetic trees was tested by bootstrapping analysis using 500 replicates. Branches corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. The nucleotide sequence data described here were submitted to the GENBANK database under the accession numbers KP888994–KP889001.


A total of 32 blood samples were collected from patients in Henan province who were infected with P. vivax. The patients came from four cities, including Nanyang city (HNNY, n = 8), Shangqiu city (HNSQ, n = 22), Zhoukou city (HNZK, n = 1), Zhumadian city (HNZMD, n = 1), and the samples were confirmed by PCR and microscopy examination. No mixed infections with other malaria parasites were detected. The CSP gene was successfully amplified for all 32 isolates with PCR products ranging from 710 to 780 bp, while isolates from patients with non-vivax malaria infection or healthy persons amplified nothing.

Sequence analysis

Direct sequencing was performed on the amplified fragments. Then the translated nucleotide sequences were analysed for polymorphisms in the pre- and post-repeat regions and central repeat of the csp gene. The central repeat sequences in all 32 isolates (100%) matched the VK210 type. All variants began with the same pre-repeat sequence (between the KLKQP region and the first repeat) and there was a lack of an inserted amino acid relative to the reference. In the central region, the sequences displayed variations, and all of the sequences had an insertion of two repeat units (GNGAGGQAA/GDRADGQPA, GNGAGGQPA/GDRAGQPA) at the beginning of the 3′ end, which is different from the classic VK210 strain. Variations were found in the post-repeat region and all isolates included a 36-bp post-repeat insert (GGNAANKKAEDA), which was previously observed in North Korean, Iranian, Anhui province and Hainan province in China [8, 31,32,33,34], and after that insertion, all isolates had two times of the repeat units (GGNA).

Taking into account the arrangement of these repeat units, eight different sub-types of VK 210 types were found. The frequency distribution of the eight sub-types is shown in Fig. 3 and Table 1. Among the eight sub-types, the most prevalent sequence variant was HN7 (37.5%, 12/32), followed by HN3 (34.4%, 11/32). In particular, the Nanyang (n = 8) and Yongcheng (n = 22) isolates displayed four (HN1, HN2, HN3, HN7) and six (HN3, HN4, HN5, HN6, HN7, HN8) different sub-types, respectively (Fig. 2).

Fig. 3

Sequence alignments of amino acid of 8 CSP distinct allelic variants found from 32 Pv isolates. Sequences were lined up to the amino acid sequences of the reference strainVK210(M28746) using ClustalW and Bio Edit software. Dashes and dots represent identical deletions and residues, respectively

Table 1 Geographic origin of isolates from Henan with CSP characteristics identified in the present study

Polymorphism of the central repeat region

All the sequences were moderately homologous but not identical to the VK210 isolate, they all included the repeat sequences of GDRADGQPA/GDRAAGQPA/GNGAGGQAA. The number of the repeat units range from 20 to 22 (Fig. 4). The repeat units were assigned as follows (Table 2).

Fig. 4

Schematic representation of the alignment of the amino acid motifs for the eight allelic CSP variants with the VK210 repeat type. A different variant is shown in each row. Dashes and dots represent identical deletions and residues, respectively

Table 2 Seven changes of amino acid sequence of the native CSP 9 peptide units in Henan province

Eight different sub-types of VK 210 were identified by simple analyses of the repeat types and the sequence FJ 601725 (China Tibet) was the most similar to the sequences found in this study. Sub-type HN7 was the dominant type in the present study, it had 20 repeat units, compared to the sequence FJ 601725. They had a non-synonymous change C→G at the 22nd nucleotide codon of the 7th repeat unit. The change A→C was found at the 14th nucleotide codon of the 9th repeat unit. There was an A→G change at the 7th nucleotide codon of the 10th repeat unit. The corresponding amino acid changes were: P→A, D→A, R→G, respectively. They present three non-synonymous changes at the 4th, 7th, 9th, and 14th nucleotide codon of the 8th repeat unit: G→A, A→G, A→T, C→G, respectively, and the repeat unit GDRAAGQPA became GNGAGGQPA. In addition, many synonymous changes were noted: C(A)→A(C) at the 3rd nucleotide codon of the 10th and 7th repeat unit, G→A at the 21st nucleotide codon of the 9th repeat unit, and T→C at the 6th nucleotide codon of the 7th repeat unit.

Repeat allotype variation

In summary, 653 repeat units (composed of a 27 bp element that can be repeated a variable time) were found in 32 Henan isolates. Nucleotide sequences were grouped in 13 unique repeat nucleotide sequence allotypes that coded for 7 different repeated amino acid allotypes (Table 2). B (GNGAGGQAA) and D (GDRAAGQPA) were more frequent in HNNY and HNYC isolates; they represented 53.9% (352/653) of the total and were coded by two different nucleotide repeat sequences. A (GDRADGQPA), F (GDRADGQAA), J (GNGAGGQPA), E (GDGAAGQPA), and K (GDRAAGQAA) were coded by 3, 2, 2, 1, and 1 nucleotide repeat sequences, respectively.

In comparison to the basic repeat units of VK210, more than 75% of the central repeat units had at least one non-synonymous nucleotide change. The variation mainly occurred in the 3rd, 4th, 6th, 7th, 9th, 14th, 21st and 22nd nucleotide codons. The 3rd and 21st codons often occur in the base transformation of silence and the 4th, 7th, 9th, 14th, and 22th codons often occur as non-synonymous nucleotide change, while the 6th nucleotide can occur as either same-sense or non-synonymous mutations.

Phylogenetic analysis

A phylogeny tree of the CSP sequences was constructed using the neighbour-joining method based on the amino acid sequences from Henan isolates and 70 published CSP sequences that were collected around the world (Fig. 5). The sequences from this study grouped into two clades. Clade A had three sub-clades that classified 19 Henan isolates and included Chinese sequences (FJ601725, AAC46499, and U08977), Hainan isolates A and B, Anhui isolates 8, 9, and 10 and MYA(EU048255), PRK(M20670). Clade B grouped the remaining 13 Henan isolates and Anhui 3, 4, 5, and 7.

Fig. 5

Dendrogram of csp gene based on the amino acid from 32 Pv Henan isolates and 70 published CSP sequences collected around the world. The tree was conducted by using the Neighbor-Joining method in MEGA version 7.0 software. The optimal tree with the sum of branch length = 1.73200559 is shown. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Poisson correction method and are in the units of the number of amino acid substitutions per site. The bootstrap values are indicated on the branches and these values show the number of times out of 500 replications. The geographical origin of the 70 CSP published sequences were as follows: Brazil (FJ845390), China (U08977–U08978, AAC46499-AAC46501, FJ601732, FJ601755, FJ601725), Columbia (KC154046, GU339085), El-Salvador (J02751), Gabon (U09737), Greece (KC896384), Honduras (DQ156131), India (KM099683, JQ308526, ACN69860, ACB38259), Indonesia (JQ308527), Iran (AAT73115, AY632261, AY632300), Mauritania (AY674050, AAV80840), Myanmar (EU048255), North Korea (AF316580, AF316581, M20670, DQ859734), Papua New Guinea (ABX71468, EU031828), Philippine (U08980–U08981, AAC46502), Solomon Island (U08982–U08983, AAC46505), South Korea (AF215741, AF316583, AF436890, AY137777, AY137778, AJ295636, AF164605), Sri Lanka (JQ362650), Thailand (M34697, HQ011320, AAA29507), Vietnam (ACB38262, EU401929), VK210 (M28746), VK247 (M28745) and Hainan and Anhui province sequences


In recent decades, csp as a major gene marker, with its previously identified 3 strains, VK210, VK 247, and P. vivax-like, was based on a central repeat domain that varies in sequences. The number of repeat units has been used successfully in epidemiological studies of P. vivax malaria [26, 27]. The VK210 strain, known as predominant or common type, identified in the study has been observed in Azerbaijan (100%) [35], Mexico (100%) [36], Pakistan (95.7%) [37], India (99.3%) [38], Afghanistan (86.6%) [39], Myanmar (98.3%) [40], Iran (82.5%) [33], Thailand (77%) [41] and Brazil (56%) [42]. VK247 has also been reported to be the predominant type in some malaria endemic areas [43, 44]. The P. vivax-like CSP variant is much less common than VK210 and VK247 around the world [45]. In China, many studies devote to investigate the ratio of two types were conducted in several provinces and the results showed that VK210 and VK247 coexisted only in Yunnan, Hainan and Liaoning provinces, whereas in other endemic provinces, such as Anhui, Hubei, Guangxi, Guangdong, Guizhou, Sichuan, Jiangsu, there was only the VK210 type [20, 46,47,48,49].

In the assessment of the DNA sequences encoding the csp gene, all the analysed P. vivax isolates from Henan province were found to belong to the VK210 common strain, which was consistent with observations from Anhui province where 45 collected P. vivax samples were also all VK210 [8]. Translated nucleotide sequences showed there were repetitive 9-mer motifs that ranged from 20 to 22 units. This was more than found in most malaria endemic areas of the world [33, 35, 41, 50]. It was possible to determine 8 different allelic types among the 32 isolates according to the arrangement of these blocks, the diversity of the Henan isolates was similar to the Anhui isolates (12/45) but less than Hainan isolates (13/27) [8, 31]. This distribution reveals that four of these VK210 variants were observed only once (HN1, HN2, HN5, and HN8). In addition, comparisons with published sequences in GENBANK were performed, since there were limited sequences of the sub-types of CSP from China. Most of the sub-types were categorized as new alleles due to different numbers of the repeat motif or different mutations in the motif with the exception of HN6, HN5, and HN 8, which were 100% identical to Hainan A, Anhui 4, and Anhui 5, respectively. Moreover, as the dominant isolates in Henan province, HN3 and HN7 were detected both in the 2008 and 2011 isolates, it suggests that the prevalent genotype remained stable from 2008 to 2011.

The geographical differences in the distribution of parasite phenotypes is directly associated with the distribution of the corresponding vector in Mexico [51]. In fact, P. vivax was transmitted by distinct Anopheline species in China, in Henan by An. sinensis and in Hainan by Anopheles dirus and Anopheles minimus, but these two provinces had the same genotypes (Hainan A, HN6). Although, the main malaria vectors were identical in Anhui and Henan provinces, their genotypes were not identical. Therefore, the broad diversity of P. vivax might be related to various factors including genetic and biological characteristics, host immunity and the migration of people within the endemic areas. In addition, relapse and early gametocytaemia of P. vivax also promote the transmission of P. vivax infections, sustaining local diversity [52].

The data in this study showed HN2 shared similar genotypes with those from North Korea (M20670), there is a possibility that these parasites have the same origin and were disseminated by travelers. The movement of infected humans is important for successful intervention strategies across the full range of transmission intensities. In the meantime, active population displacements and movement between countries have exploded facilitating the spread of the diseases throughout the country and the world [53, 54]. Infected individuals might carry multiple clones with different csp variants, which may recombine during the sexual stage in the mosquito producing offspring with new csp genotypes. This widespread occurrence could support new malaria strain introduction into new regions with receptive conditions for malaria transmission [55]. Human population movement from higher transmission area risks reintroduction and resurgence in malaria-free receptive areas, and has undermined efforts in the past [56]. Thus, knowledge of parasite population genetics could be of assistance in designing and monitoring strategies for elimination of the parasite.


In summary, P. vivax circulating in Henan province have some degree of genetic diversity in CSP, with 8 sub-types among 32 samples, and the subtypes HN1, HN2, HN3, HN4, HN7 have not been reported before. Meantime, the results also showed that P. vivax populations in this region had major genotypes: HN7 (37.5%) and HN3 (34.4%), suggesting its relative conserved parasite populations. The declining incidence of P. vivax cases constrained the sample size of the current study, although the two key malaria areas of Henan, Nanyang and Shangqiu, were moderately well represented in sample size, the limited information on the region were obtained. Still, CSP alone is not a perfect measure of the actual parasite genetic diversity. As such, the polymorphism shown by CSP is relatively typical and consistent with the one observed in other endemic areas. This could provide interesting baseline data that allow identifying whether potential new cases differ from the parasites already circulating in the area.



circumsporozoite protein gene


ethylene diamine tetraacetic acid


  1. 1.

    World Health Organization. World malaria report. Geneva: World Health Organization; 2017.

    Google Scholar 

  2. 2.

    Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77:79–87.

    PubMed  PubMed Central  Google Scholar 

  3. 3.

    Schousboe ML, Ranjitkar S, Rajakaruna RS, Amerasinghe PH, Konradsen F, Morales F, et al. Global and local genetic diversity at two microsatellite loci in Plasmodium vivax parasites from Asia, Africa and South America. Malar J. 2014;13:392.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004;4:327–36.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Carlton JM, Sina BJ, Adams JH. Why is Plasmodium vivax a neglected tropical disease? PLoS Negl Trop Dis. 2011;5:e1160.

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Preston MD, Campino S, Assefa SA, Echeverry DF, Ocholla H, Amambua-Ngwa A, et al. A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains. Nat Commun. 2014;5:4052.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Lu G, Zhou S, Horstick O, Wang X, Liu Y, Muller O. Malaria outbreaks in China (1990–2013): a systematic review. Malar J. 2014;13:269.

    Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Huang B, Huang SG, Su XZ, Guo H, Xu YC, Xu F, et al. Genetic diversity of Plasmodium vivax population in Anhui province of China. Malar J. 2014;13:13.

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Zhou SX, Wang Y, Xia ZG. Malaria Situation in the People’s Republic of China in 2009. Chin J Parasitol Parasit Dis. 2011;29:1–3.

    Google Scholar 

  10. 10.

    Zhou SS, Wang Y, Li Y. Malaria Situation in the People’s Republic of China in 2010. Chin J Parasitol Parasit Dis. 2011;29:401–3.

    Google Scholar 

  11. 11.

    Xia ZG, Yang MN, Zhou SS. Malaria Situation in the People’s Republic of China in 2011. Chin J Parasitol Parasit Dis. 2012;30:419–22.

    Google Scholar 

  12. 12.

    Li YN, Wen L, Li CY, Zhang WY, Sun HL, Zou W. Descriptive analysis of trends of malaria prevalence in China from 2006 to 2010. Chin J Public Health. 2013;29:263–5.

    Google Scholar 

  13. 13.

    Zhang HW, Su YP, Xu BL. A review of malaria control and research in Henan Province of China. J Pathog Biol. 2006;1:64–6.

    CAS  Google Scholar 

  14. 14.

    Xu BL, Su YP, Liu Y. Malaria evaluation on the control effect in Henan Province during 1970–2010. Henan J Prev Med. 2011;22:321–6.

    CAS  Google Scholar 

  15. 15.

    Chao X, Qing-kuan W, Xiang-li K, Jin L, Yong-bin W, Ting X, et al. Allele genotypes and homology analysis of MSP-1 and CSP gene of Plasmodium vivax in Shandong Province. Chin J Schistosomiasis Control. 2017;29:38–43.

    Google Scholar 

  16. 16.

    Yu-chun L, Shan-qing W, Xi-min H, Guang-ze W, Feng M, Wen Z, et al. Polymorphism in merozoite surface protein-1 of Plasmodium vivax before malaria elimination in Hainan Island. Chin J Zoonoses. 2014;30:219–22.

    Google Scholar 

  17. 17.

    Yin-fa Z, Shan-ying Z, Fa-zhu Y, Han-guo X, Yao-ying L, Fang-zhen X. Study of the genetic diversity of Plasmodium vivax AMA-1. J Pathog Biol. 2015;10:801–4.

  18. 18.

    Xu C, Xu XL, Huang BC. Research progress on polymorphism in the merozoite surface protein-3α gene of Plasmodium vivax. Chin J Parasitol Parasit Dis. 2013;31(6):473–6.

    Google Scholar 

  19. 19.

    Ying D, Ai-ming S, Meng-ni C, Yan-chun X, Xiang-hua M, Yan D. Polymorphism analysis of the block 5 region in merozoite surface protein-1 gene of imported and local Plasmodium vivax in Yunnan Province. Chin J Parasitol Parasit Dis. 2017;35:1–7.

  20. 20.

    Geng YZ, Tian J, Teng C. Genotyping of Plasmodium vivax in Liaoning Province via the circumsporozoite protein. J Pathog Biol. 2012;7:344–6.

    Google Scholar 

  21. 21.

    Miao M, Yang Z, Patch H, Huang Y, Escalante AA, Cui L. Plasmodium vivax populations revisited: mitochondrial genomes of temperate strains in Asia suggest ancient population expansion. BMC Evol Biol. 2012;12:22.

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Huang YT, Lu XM, Jin XB, Zhu JY. Research advances on circumsporzoite protein of Plasmodium. Chin J Parasitol Parasit Dis. 2012;30:238–42.

    Google Scholar 

  23. 23.

    Coppi A, Natarajan R, Pradel G, Bennett BL, James ER, Roggero MA, et al. The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. J Exp Med. 2011;208:341–56.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Liu Y, Zhang H, Zhou R, Yang C, Qian D, Zhao Y, et al. First imported relapse case of Plasmodium vivax malaria and analysis of its origin by CSP sequencing in Henan Province. China. Malar J. 2014;13:448–53.

    Article  PubMed  Google Scholar 

  25. 25.

    Alves RT, Povoa MM, Goldman IF, Cavasini CE, Rossit AR, Machado RL. A new polymerase chain reaction/restriction fragment length polymorphism protocol for Plasmodium vivax circumsporozoite protein genotype (VK210, VK247, and P. vivax-like) determination. Diagn Microbiol Infect Dis. 2007;59:415–9.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Rosenberg R, Wirtz R, Lanar D, Sattabongkot J, Hall T, Waters A, et al. Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Science. 1989;245:973–6.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Qari S, Shi YP, Goldman I, Udhayakumar V, Alpers M, Collins W, et al. Identification of Plasmodium vivax-like human malaria parasite. Lancet. 1993;341:780–3.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Su YP, Feng SX, He LJ, Chen JS. Current status of malaria prevalence in Henan Province and the strategy for prevention. Henan J Prev Med. 2001;12:195–7.

    Google Scholar 

  29. 29.

    Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario V, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315–20.

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, Looareesuwan S, et al. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J. 2005;4:20.

    Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Li YC, Wang GZ, Meng F, Zeng W, He CH, Hu XM, et al. Genetic diversity of Plasmodium vivax population before elimination of malaria in Hainan Province, China. Malar J. 2015;14:78.

    Article  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Qari S, Goldman I, Povoa M, Santi S, Alpers M, Lal A. Polymorphism in the circumsporozoite protein of the human malaria parasites Plasmodium vivax. Mol Biochem Parasitol. 1992;55:105–14.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Zakeri S, Abouie Mehrizi A, Djadid ND, Snounou G. Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran. Trop Med Int Health. 2006;11:729–37.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Huang T, Cheng Q, Allan S, Huang Y. DNA sequencing of circumsporozoite protein genes of Plasmodium vivax from four different countries in west pacific region: comparative study on the flank sequences. Chin J Parasitol Parasit Dis. 1994;12:85–92.

    CAS  Google Scholar 

  35. 35.

    Leclerc MC, Menegon M, Cligny A, Noyer JL, Mammadov S, Aliyev N, et al. Genetic diversity of Plasmodium vivax isolates from Azerbaijan. Malar J. 2004;3:40.

    Article  PubMed  PubMed Central  Google Scholar 

  36. 36.

    Gonzalez-Ceron L, Rodriguez MH, Nettel JC, Villarreal C, Kain KC, Hernandez JE. Differential susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to infections with coindigenous Plasmodium vivax variants VK210 and VK247 in southern Mexico. Infect Immun. 1999;7:410–2.

    Google Scholar 

  37. 37.

    Zakeri S, Raeisi A, Afsharpad M, Kakar Q, Ghasemi F, Atta H, et al. Molecular characterization of Plasmodium vivax clinical isolates in Pakistan and Iran using pvmsp-1, pvmsp-3alpha and pvcsp genes as molecular markers. Parasitol Int. 2010;59:15–21.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Kim JR, Imwong M, Nandy A, Chotivanich K, Nontprasert A, Tonomsing N, et al. Genetic diversity of Plasmodium vivax in Kolkata, India. Malar J. 2006;5:71.

    Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Zakeri S, Safi N, Afsharpad M, Butt W, Ghasemi F, Mehrizi AA, et al. Genetic structure of Plasmodium vivax isolates from two malaria endemic areas in Afghanistan. Acta Trop. 2010;113:12–9.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Moon SU, Lee HW, Kim JY, Na BK, Cho SH, Lin K, et al. High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar. Acta Trop. 2009;109:30–6.

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Cui LW, Mascorro CN, Fan Q, Rzomp KA, Khuntirat B, Zhou G, et al. Genetic diversity and multiple infections of Plasmodium vivax malaria in western Thailand. Am J Trop Med Hyg. 2003;685:613–9.

    Article  Google Scholar 

  42. 42.

    de Paulo Ribeiro B, Cassiano GC, de Souza RM, Cysne DN, Grisotto MA, de Azevedo dos Santos AP, et al. Polymorphisms in Plasmodium vivax circumsporozoite protein (CSP) influence parasite burden and cytokine balance in a pre-amazon endemic area from Brazil. PLoS Negl Trop Dis. 2016;10:e0004479.

    Article  Google Scholar 

  43. 43.

    González-Cerón L, Martinez-Barnetche J, Montero-Solís C, Santillán F, Soto AM, Rodríguez MH, et al. Molecular epidemiology of Plasmodium vivax in Latin America polymorphism and evolutionary relationships of the circumsporozoite gene. Malar J. 2013;12:243.

    Article  PubMed  PubMed Central  Google Scholar 

  44. 44.

    Chenet SM, Tapia LL, Escalante AA, Durand S, Luca C, Bacon DJ. Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax. Malar J. 2012;11:68.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Cheng Y, Ito D, Sattabongkot J, Lim CS, Kong DH, Ha KS, et al. Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population. Malar J. 2013;12:323–33.

    Article  PubMed  PubMed Central  Google Scholar 

  46. 46.

    Huang TY, Victoria HM, Huang YM, Wang XL, Allan S. Characteristics of polymorphism of circumsporozoite protein gene of Plasmodium vivax of different geographical strains. Chin J Parasitol Parasit Dis. 2001;19:260–4.

    CAS  Google Scholar 

  47. 47.

    Li XM, Guo CK, Li JH, Huang YM, Du JF, Fu WZ. A discussion on the CSP genotyping of Plasmodium vivax and malaria control in five southern provinces of China. Chin J Parasitol Parasit Dis. 2005;23:274–82.

    Google Scholar 

  48. 48.

    Xu GQ, Zhang ZX, Li N, Dai HJ. Genotyping of Plasmodium vivax in China–Myanmar border by circumsporozoite protein. Chin J Parasitol Parasit Dis. 2010;28:265–7.

    Google Scholar 

  49. 49.

    Yan JZ, Hu LQ, Zhang SQ, Xu BZ, David CW. Analysis of partial sequence of circumsporozoite protein of Plasmodium vivax isolates in Hubei province. Chin J Parasitol Parasit Dis. 1997;15:152–5.

    Google Scholar 

  50. 50.

    Ana CL, Andres O, Jorge C, Wilfredo SO, Rosa EMT, Engels IB, et al. Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Honduras. Malar J. 2012;11:391.

    Article  Google Scholar 

  51. 51.

    Rodriguez MH, Gonzalez-Ceron L, Hernandez JE, Nettel JA, Villarreal C, Kain KC, et al. Different prevalences of Plasmodium vivax phenotypes VK210 and VK247 associated with the distribution of Anopheles albimanus and Anopheles pseudopunctipennis in Mexico. Am J Trop Med Hyg. 2000;62:122–7.

    CAS  Article  PubMed  Google Scholar 

  52. 52.

    Barry AE, Waltmann A, Koepfli C, Barnadas C, Mueller I. Uncovering the transmission dynamics of Plasmodium vivax using population genetics. Pathog Glob Health. 2015;109:142–52.

    Article  PubMed  PubMed Central  Google Scholar 

  53. 53.

    Choi KM, Choi YK, Kang YA, Seo SY, Lee HW, Cho SH, et al. Study of the genetic discrimination between imported and autochthonous cases of malaria in South Korea. J Travel Med. 2011;18:63–6.

    Article  PubMed  Google Scholar 

  54. 54.

    Snowden FM. Emerging and reemerging diseases: a historical perspective. Immunol Rev. 2008;225:9–26.

    Article  PubMed  Google Scholar 

  55. 55.

    Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, et al. The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Nat Genet. 2012;44:1046–50.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  56. 56.

    Pindolia DK, Garcia AJ, Huang Z, Smith DL, Alegana VA, Noor AM, et al. The demographics of human and malaria movement and migration patterns in East Africa. Malar J. 2013;12:397.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Authors’ contributions

YL, RMZ and HWZ conceived the study. DQ analysed the data. YLZ, SHL and CYY participated in the study. YL drafted the manuscript. BLX, DQW and YLZ revised the manuscript. All authors read and approved the final manuscript.


The authors thank Dr. Jimee Hwang for editing the manuscript. We also thank the health workers and field team who participated in the study.

Competing interests

No conflict of interest of any kind occurred or exists in the framework of this study.

Availability of data and materials

The datasets used during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study protocol was reviewed and approved by the Ethical Review Committee of Henan CDC. The survey participant or his/her parents or guardian gave fully informed consent to participate in this study.


This work was supported by Henan Provincial Health and Family Planning Commission (201602318).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information



Corresponding author

Correspondence to Ying Liu.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Zhou, R., Zhang, Y. et al. Analysis of polymorphisms in the circumsporozoite protein gene of Plasmodium vivax isolates from Henan Province, China. Malar J 17, 103 (2018).

Download citation


  • Plasmodium vivax
  • CSP
  • Diversity
  • Henan
  • China